We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Best "Strong Buy" Stocks Trading Near Their Highs to Buy as the Nasdaq Falls
Read MoreHide Full Article
Key Takeaways
How to find the best Zacks Rank #1 (Strong Buy) momentum stocks to buy now amid the AI-driven selloff.
Buy soaring home and community-based health services stocks BTSG and hold for long-term upside.
The AI-driven selloff is ramping up again, spurred by the rapid downfall of Nvidia CEO Jensen Huang.
The Nasdaq is officially in correction territory again, closing ~12% below its early October high on November 17. This backdrop might leave some investors fearful and running to the sidelines.
But moving to the sidelines and trying to play the market-timing game is extremely difficult. Attempting to time the market exactly can also crush your long-term returns if you get it wrong.
Today, we highlight how to find surging Zacks Rank #1 (Strong Buy) stocks that are thriving and trading near their 52-week highs even as the broader market tanks and AI stocks tumble.
The momentum stocks this screen puts on your radar are experiencing strong positive earnings revisions, earning them Zacks Rank #1 (Strong Buys). Let’s dive into how investors can find the best "Strong Buy" momentum stocks to buy right now as the Nasdaq hits correction territory.
Screen Basics: Finding the Best Momentum Stocks to Buy Now
The screen we are looking into today comes loaded with the Research Wizard. The screen helps investors dig through all of the Zacks Rank #1 (Strong Buy) stocks, of which there are over 200 at any given time, to find some of the top momentum names.
The screen narrows down the list of Zacks Rank #1 (Strong Buy) stocksto those with upward price momentum that are also trading within 20% of their 52-week highs. The screen then uses the PEG ratio and the Price to Sales ratio to help make sure investors are getting value as well. The screen then makes your life a little easier and narrows it down to just seven stock picks.
The screen basics are listed below…
· Zacks Rank = #1 (Strong Buy)
· Current Price/52-week High >= 0.8
· PEG Ratio: P/E F(1)/EPS Growth <= 1
· Price/Sales <= 3
· Percentage Change Price -12 Weeks = Top # 7
This strategy comes loaded with the Research Wizard and it is called bt_sow_momentum_method1 It can be found in the SoW (Screen of the Week) folder.
The screen is simple, yet powerful. Here is one of the seven stocks that made it through this week's screen…
Buy and Hold Soaring Home Healthcare Stock BTSG Amid the Market Selloff
At-home-focused healthcare stock BrightSpring Health Services, Inc. (BTSG - Free Report) has skyrocketed ~535% since its early 2024 IPO, including an 86% YTD charge to blow away its sector and the S&P 500. The stock is trading roughly 4% below its peaks (late July and November 11), while its average Zacks price target implies ~16% upside.
Plus, 18 out of the 19 brokerage recommendations that Zacks has for BrightSpring are “Strong Buys,” and its Medical Services industry is in the top 23% of roughly 250 Zacks industries.
Image Source: Zacks Investment Research
The booming U.S. health services company provides care and services to people with complex medical needs right in their homes or communities, rather than in hospitals. BrightSpring operates across two main lines of business: pharmacy services and provider services.
Its pharmacy segment delivers specialized medications, including infusions and injectables. BTSG’s provider unit focuses on home health nursing, physical therapy, behavioral health support, rehabilitation, and more.
Image Source: Zacks Investment Research
BrightSpring is projected to expand its sales by 24% in 2026 and another 14% in FY27 to reach $18.10 billion vs. $12.91 billion in FY25 and $10.07 billion in 2024. Plus, its adjusted earnings are expected to surge 91% in 2026 and 31% next year, more than doubling from $1.00 in FY25 to $2.50 per share next year.
The community-based health services stock’s recent positive earnings revisions land BrightSpring a Zacks Rank #1 (Strong Buy) and extend its impressive run of upward revisions.
Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.
Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
Best "Strong Buy" Stocks Trading Near Their Highs to Buy as the Nasdaq Falls
Key Takeaways
The AI-driven selloff is ramping up again, spurred by the rapid downfall of Nvidia CEO Jensen Huang.
The Nasdaq is officially in correction territory again, closing ~12% below its early October high on November 17. This backdrop might leave some investors fearful and running to the sidelines.
But moving to the sidelines and trying to play the market-timing game is extremely difficult. Attempting to time the market exactly can also crush your long-term returns if you get it wrong.
Today, we highlight how to find surging Zacks Rank #1 (Strong Buy) stocks that are thriving and trading near their 52-week highs even as the broader market tanks and AI stocks tumble.
The momentum stocks this screen puts on your radar are experiencing strong positive earnings revisions, earning them Zacks Rank #1 (Strong Buys). Let’s dive into how investors can find the best "Strong Buy" momentum stocks to buy right now as the Nasdaq hits correction territory.
Screen Basics: Finding the Best Momentum Stocks to Buy Now
The screen we are looking into today comes loaded with the Research Wizard. The screen helps investors dig through all of the Zacks Rank #1 (Strong Buy) stocks, of which there are over 200 at any given time, to find some of the top momentum names.
The screen narrows down the list of Zacks Rank #1 (Strong Buy) stocksto those with upward price momentum that are also trading within 20% of their 52-week highs. The screen then uses the PEG ratio and the Price to Sales ratio to help make sure investors are getting value as well. The screen then makes your life a little easier and narrows it down to just seven stock picks.
The screen basics are listed below…
· Zacks Rank = #1 (Strong Buy)
· Current Price/52-week High >= 0.8
· PEG Ratio: P/E F(1)/EPS Growth <= 1
· Price/Sales <= 3
· Percentage Change Price -12 Weeks = Top # 7
This strategy comes loaded with the Research Wizard and it is called bt_sow_momentum_method1 It can be found in the SoW (Screen of the Week) folder.
The screen is simple, yet powerful. Here is one of the seven stocks that made it through this week's screen…
Buy and Hold Soaring Home Healthcare Stock BTSG Amid the Market Selloff
At-home-focused healthcare stock BrightSpring Health Services, Inc. (BTSG - Free Report) has skyrocketed ~535% since its early 2024 IPO, including an 86% YTD charge to blow away its sector and the S&P 500. The stock is trading roughly 4% below its peaks (late July and November 11), while its average Zacks price target implies ~16% upside.
Plus, 18 out of the 19 brokerage recommendations that Zacks has for BrightSpring are “Strong Buys,” and its Medical Services industry is in the top 23% of roughly 250 Zacks industries.
Image Source: Zacks Investment Research
The booming U.S. health services company provides care and services to people with complex medical needs right in their homes or communities, rather than in hospitals. BrightSpring operates across two main lines of business: pharmacy services and provider services.
Its pharmacy segment delivers specialized medications, including infusions and injectables. BTSG’s provider unit focuses on home health nursing, physical therapy, behavioral health support, rehabilitation, and more.
Image Source: Zacks Investment Research
BrightSpring is projected to expand its sales by 24% in 2026 and another 14% in FY27 to reach $18.10 billion vs. $12.91 billion in FY25 and $10.07 billion in 2024. Plus, its adjusted earnings are expected to surge 91% in 2026 and 31% next year, more than doubling from $1.00 in FY25 to $2.50 per share next year.
The community-based health services stock’s recent positive earnings revisions land BrightSpring a Zacks Rank #1 (Strong Buy) and extend its impressive run of upward revisions.
Get the rest of the stocks on this list and start looking for the newest companies that fit these criteria. It's easy to do. And it could help you find your next big winner. Start screening for these companies today with a free trial to the Research Wizard. You can do it.
Click here to sign up for a free trial to the Research Wizard today.
Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: www.zacks.com/performance_disclosure